前列腺癌患者的性功能障碍根据疾病阶段和治疗方式
W Kinnaird1, P Schartau2, M Kirby3
1University College London, Gower Street, WC1E 6BT, London, UK; University College London Hospitals NHS Foundation Trust, 235 Euston Road, London NW1 2BU, UK.
概括
前列腺癌 (PCa) 治疗在98%以上的患者中引起广泛的性功能障碍 (SD),影响身体和心理健康. 先进的疾病和组合疗法加剧了这些影响,凸显了全面康复的需要.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 性医学性医学性医学性医学
背景情况:
- 前列腺癌 (PCa) 的诊断和治疗显著影响患者的生活质量.
- 性功能障碍 (SD) 是一种普遍而令人痛苦的副作用,影响身体和心理领域.
- 了解SD在不同疾病阶段和治疗方法中的细微差别对于患者护理至关重要.
研究的目的:
- 调查前列腺癌 (PCa) 患者身体和心理性功能障碍 (SD) 的患病率和特征.
- 分析疾病阶段和治疗方式如何影响性副作用的体验.
- 确定与性康复相关的患者支持需求.
主要方法:
- 对654名PCa患者进行了在线调查,评估了13个领域的性副作用,性功能的重要性和支持需求.
- 收集了关于疾病阶段 (局部,局部发达,高级) 和治疗 (根性前列腺切除术,放射治疗,雄激素剥夺疗法) 的数据.
- 描述性统计和千二测试用于数据分析.
主要成果:
- 超过98%的PCa患者在治疗后报告了新的性问题.
- 常见的身体功能障碍包括勃起功能障碍 (91.0%),射精障碍 (82.9%) 和阴茎解剖变化 (70.0%).
- 心理性功能障碍很普遍,性自信的丧失 (76.2%),性欲的丧失 (67.1%) 和自尊的丧失 (57.1%) 是最常见的. 晚期疾病和组合疗法 (RP,RT,ADT) 与较高的SD率有关.
结论:
- 性功能障碍是PCa治疗的常见,严重和痛苦的后果,患者高度重视性恢复.
- 晚期PCa患者和接受组合疗法,特别是永久ADT的患者,经历最严重的SD,包括显著的性心理问题.
- 针对广泛性副作用的整体康复策略对于所有PCa幸存者至关重要,特别是那些长期使用ADT的人.
相关概念视频
Disorders of the Male Reproductive System
283
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
283
Male Sexual Response: Erection & Ejaculation
1.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
1.3K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
121
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
121


